Entero Healthcare Solutions Limited has officially scheduled a meeting of its Board of Directors for Monday, May 25, 2026. The primary objective of this session is to review, deliberate, and approve the company’s audited standalone and consolidated financial results for the quarter and the full financial year that concluded on March 31, 2026.
Upcoming Financial Disclosure
The management of Entero Healthcare Solutions has confirmed that the Board of Directors will convene on May 25, 2026. This meeting is a critical governance event aimed at finalizing the financial performance of the company for the period ended March 31, 2026. The board will evaluate both standalone and consolidated financial statements, providing shareholders and the market with a comprehensive view of the company’s fiscal health for the year.
Trading Window Restrictions
In accordance with the internal code of conduct for maintaining market integrity, the company has implemented a trading window closure. This restriction, which has been in effect since April 01, 2026, applies to all designated persons and their immediate relatives. The trading window will remain locked until the expiration of 48 hours following the public announcement of the financial results, ensuring that all material information is disseminated fairly to the investing public.
Source: BSE
